Despite Changmao Biochemical Engineering's higher revenue gr...
Despite Changmao Biochemical Engineering's higher revenue growth, its P/S ratio aligns with the industry, possibly due to potential risks. Investors anticipate future revenue volatility.
Market Cool On Changmao Biochemical Engineering Company Limited's (HKG:954) Revenues Pushing Shares 28% Lower
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4561Followers
0Following
9968Visitors
Follow